9th Circ. Revives Atty's FCA Suit Against Valeant Over Apriso
The Ninth Circuit on Thursday revived a False Claims Act suit accusing Valeant Pharmaceuticals of fraudulently obtaining a patent to prolong its monopoly on its drug Apriso, finding the statute's public...To view the full article, register now.
Already a subscriber? Click here to view full article